Superstring Capital Management as of March 31, 2024
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 37 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 12.9 | $20M | 279k | 70.11 | |
| Nkarta (NKTX) | 8.5 | $13M | 1.2M | 10.81 | |
| 89bio (ETNB) | 7.2 | $11M | 941k | 11.64 | |
| Bridgebio Pharma (BBIO) | 7.2 | $11M | 354k | 30.92 | |
| Savara (SVRA) | 6.8 | $10M | 2.1M | 4.98 | |
| Ideaya Biosciences (IDYA) | 6.3 | $9.5M | 217k | 43.88 | |
| Fate Therapeutics (FATE) | 4.5 | $6.8M | 921k | 7.34 | |
| Day One Biopharmaceuticals I (DAWN) | 3.8 | $5.8M | 350k | 16.52 | |
| Roivant Sciences SHS (ROIV) | 3.7 | $5.6M | 531k | 10.54 | |
| Ionis Pharmaceuticals (IONS) | 3.5 | $5.2M | 121k | 43.35 | |
| Marinus Pharmaceuticals Com New (MRNS) | 3.4 | $5.1M | 566k | 9.04 | |
| Cabaletta Bio (CABA) | 3.3 | $5.0M | 291k | 17.06 | |
| Urogen Pharma (URGN) | 2.9 | $4.3M | 288k | 15.00 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.8 | $4.2M | 259k | 16.09 | |
| Aerovate Therapeutics (AVTE) | 2.2 | $3.3M | 110k | 29.57 | |
| Apogee Therapeutics (APGE) | 2.0 | $3.0M | 45k | 66.45 | |
| Axsome Therapeutics (AXSM) | 1.9 | $2.9M | 37k | 79.80 | |
| Dyne Therapeutics (DYN) | 1.9 | $2.8M | 100k | 28.39 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.6 | $2.4M | 40k | 61.02 | |
| Allogene Therapeutics (ALLO) | 1.5 | $2.3M | 521k | 4.47 | |
| Keros Therapeutics (KROS) | 1.5 | $2.2M | 34k | 66.20 | |
| Pyxis Oncology Common Stock (PYXS) | 1.4 | $2.1M | 494k | 4.26 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.3 | $1.9M | 13k | 151.17 | |
| Pepgen (PEPG) | 1.1 | $1.7M | 114k | 14.70 | |
| Tourmaline Bio (TRML) | 1.1 | $1.6M | 70k | 22.90 | |
| Allakos (ALLK) | 1.0 | $1.6M | 1.2M | 1.26 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $1.5M | 679k | 2.18 | |
| Annexon (ANNX) | 0.7 | $1.1M | 156k | 7.17 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $945k | 37k | 25.52 | |
| Lyra Therapeutics (LYRA) | 0.6 | $904k | 145k | 6.22 | |
| Inozyme Pharma (INZY) | 0.6 | $864k | 113k | 7.66 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $494k | 99k | 5.01 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $380k | 32k | 11.86 | |
| Alpine Immune Sciences | 0.2 | $358k | 9.0k | 39.64 | |
| Spruce Biosciences (SPRB) | 0.2 | $346k | 440k | 0.79 | |
| Ys Biopharma Ordinary Shares (LSB) | 0.1 | $216k | 308k | 0.70 | |
| So Young International Sponsored Ads (SY) | 0.1 | $199k | 183k | 1.09 |
